Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 5 of 5 for “"5-Aza-dC"”.

  1. The Analysis of the MCF7 Cancer Model System and the Effects of 5-AZA-2'-Deoxycytidine Treatment on the Chromantin State Using a Novel Microarray-Based Technology for High Resolution Global Chromatin State Measurement

    … demonstrated in a MCF7 cell line treated with 5 Aza dC, which disrupts genome methylation, and as a result causes global relaxation of chromatin structure. 5 Aza dC treatment results in strong changes in expression, and a normalized global chromatin relaxation of two-fold. A significant subset of …

    utswmed Repository record for The Analysis of the MCF7 Cancer Model System and the Effects of 5-AZA-2'-Deoxycytidine Treatment on the Chromantin State Using a Novel Microarray-Based Technology for High Resolution Global Chromatin State Measurement (opens in a new tab)

  2. Epigenetic silencing of gene expression in paediatric astrocytoma

    … efficacy of a DNA methyltransferase inhibitor, 5-Aza-dC in paediatric HGA. There were 147 genes commonly identified to be potentially methylated in IN699 cells using the two different array strategies integration; re-expression array and Illumina Infinium Human Methylation 450k array. Furthermore, …

    wlv Repository record for Epigenetic silencing of gene expression in paediatric astrocytoma (opens in a new tab)

  3. Investigating the molecular dynamics of gene re-silencing following treatment with epigenetic therapies

    … in cancer. DNA hypomethylating agents such as 5-Aza-2’deoxycytidine (5-Aza-dC) are approved for the treatment of myelodysplastic syndrome and show promise in the treatment of solid tumours. These therapies are thought to exert their anti-tumour effects by reactivating hypermethylated genes. …

    unsw Repository record for Investigating the molecular dynamics of gene re-silencing following treatment with epigenetic therapies (opens in a new tab)

  4. Aberrant epigenetics in the molecular pathogenesis of human acute myeloid leukemia

    … p15 mRNA. Treatment with the cytosine analog 5-Aza-2’-deoxycytidine (5-Aza-dC) in vitro resulted in promoter demethylation and p15 mRNA re-expression, which was associated with a release of a transcriptionally repressive complex at the p15 promoter. Importantly, 5-Aza-dC treatment also reversed …

    sask Repository record for Aberrant epigenetics in the molecular pathogenesis of human acute myeloid leukemia (opens in a new tab)

  5. Functional consequences of cytosine methylation in mitochondrial DNA catalyzed by DNA methyltransferase 1

    … inhibition by the nucleoside analog 5-aza-2’-deoxycytidine (5-aza-dC). NRF1 and PGC1α, transcription factors that activate nuclear-encoded mitochondrial proteins in response to oxidative stress, were observed to up-regulate expression of mtDNMT1. Loss of p53, a tumor suppressor gene …

    vcu Repository record for Functional consequences of cytosine methylation in mitochondrial DNA catalyzed by DNA methyltransferase 1 (opens in a new tab)